SynOx Therapeutics
Pre-clinicalSynOx Therapeutics is a biopharmaceutical company developing monoclonal antibodies for the treatment of tenosynovial giant cell tumor and other solid tumors.
Founded
2019
Focus
AntibodiesBiologics
About
SynOx Therapeutics is a biopharmaceutical company developing monoclonal antibodies for the treatment of tenosynovial giant cell tumor and other solid tumors.
Funding History
1Total raised: $37M
Series A$37MHealthCapJan 15, 2021
Company Info
TypePrivate
Founded2019
LocationDublin, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile